Co-Co, NewCo, and Early Overseas Expansion: Three New Paths for Chinese Innovative Drugs Going Global
Opening Introduction: In the first half of 2026, the total overseas licensing transaction volume of China’s innovative drugs will exceed $110 billion, accounting for 80% of
